Hyun Kim, MD

Dr. Kim is the Director of the Interstitial Lung Disease program and supervises ILD clinical trials. She established the University of Minnesota ILD database in 2010 to answer questions about natural history and outcomes of ILD. She led the ILD program to achieve recognition as a Pulmonary Fibrosis Foundation Care Center Network site, which identifies pulmonary fibrosis centers that provide leading clinical care and research. She also organizes the University of Minnesota Pulmonary Fibrosis Patient Education Day, a biennial free symposium for patients and families with pulmonary fibrosis that provides the latest updates in pulmonary fibrosis care and research. Her clinical expertise centers on treating patients with interstitial lung disease, including idiopathic pulmonary fibrosis, chronic hypersensitivity pneumonitis, IgG4-related lung disease, airway-centered interstitial fibrosis, scleroderma lung disease, other connective tissue disease-related lung diseases and rare ILDs. Her research interests include natural history and outcomes in idiopathic pulmonary fibrosis, pharmacogenomics of anti-fibrotic medications, non-pharmacologic treatments for ILDs, and clinical trials in ILD.

• University of Minnesota Pulmonary and Critical Care Medicine Fellowship Teacher of the Year Award, 2011, 2012, 2015
• Best Doctors for Women, Minnesota Monthly 2011, 2013
• Boehringer Ingelheim Educational Grant ($10,000) to support the University of Minnesota Pulmonary Fibrosis Patient Education Day, 2014, 2015
• Genentech Educational Grant to support the University of Minnesota Pulmonary Fibrosis Patient Education Day, 2015 & 2017
• Minnesota Monthly Magazine Best Doctors 2014 – 2017
• Best Doctors in America, 2013 – 2017
• Educational Excellence Award, University of Minnesota Department of  Medicine, 2017
• Top Doctors in the Twin Cities, Mpls/StPaul Magazine 2012 – 2018

• American Thoracic Society
• American College of Chest Physicians

• Kim HJ, Ingbar DH, Henke CA. Integrin mediation of type II cell adherence to provisional matrix proteins. Am J Physiol 271 (Lung Cell Mol Physiol 15):L277-L286, 1996. 
• Kim HJ, Henke CA, Ingbar DH. Integrin mediation of alveolar epithelial cell migration on fibronectin and type I collagen. Am J Physiol 273 (Lung Cell Mol Physiol 17):L134-L141, 1997.
• Elmuldi F, Henke CA, Perlman DM, Tomic R, Kim HJ. Novel mechanisms and treatment of idiopathic pulmonary fibrosis. Discovery Medicine 2015;20(109):145-153.
• Fortis S, Corazalla E, Jacobs Jr DR, Kim HJ. Persistent empiric COPD diagnosis and treatment after pulmonary function test showed no obstruction. Respir Care 2016;61(9):1192-1200
• Thao C, Lagstein A, Allen T, Dincer HE, Kim HJ. Crohn’s disease-associated interstitial lung disease mimicking sarcoidosis: a case report and review of the literature. Sarcoidosis Vasc Diffuse Lung Dis 2016;33(3):288-291.
• Kim HJ, Perlman D, Tomic R. Natural History of Idiopathic Pulmonary Fibrosis. Respiratory Medicine 2015; doi:10.1016/j.med.2015.02.002
• Keenan J, Miller E, Jessurun J, Allen T, Kim HJ. IgG4-related disease of the lung: A Case Series of 6 patients and review of the literature. Sarcoidosis Vasculitis and Diffuse Lung Diseases. In press.
• Kim HJ and Bitterman PB. Peptide growth factors and matrix signals in idiopathic pulmonary fibrosis. In Lung Biology in Health and Disease: Idiopathic Pulmonary Fibrosis, pp563-572. Joseph P. Lynch, ed. Marcel Dekker, Inc., New York, NY. 2004.
• Kim HJ, and Ingbar DH. Acute Respiratory Failure. In Pulmonary/Respiratory Therapy Secrets, pp. 459-468. 3rd edition. PE Parsons and JE Heffner, eds. Mosby Elsevier Philadelphia, PA. 2006.
• Kannapiran M and Kim H. Diagnostic evaluation of the patient with interstitial lung disease. Clinical Pulmonary Medicine, 19(2):71-77, 2012.
• Fortis S, Corazalla E, Wang Q, Kim HJ. The difference between SVC and FVC increases with increasing BMI: a paradoxical difference in low and normal BMIs. Respiratory Care. In press.
• Perlman DM, Bhargava M, Kim HJ, Ritter JH, Tomic R. Acute exacerbation of idiopathic pulmonary fibrosis. Clin Pulm Med 2014;21:262-268.
• Tomic R, Kim HJ, Bors M, Allen T, Ritter J, Dincer EH, Perlman DM, Bhargava M. Significance of Granulomatous Inflammation in Usual Interstitial Pneumonia. Sarcoidosis Vasculitis and Diffuse Lung Diseases. In press.
• Loor G, Kim HJ, Perlman D, Tomic R. Considerations for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis. Clinical Pulmonary Medicine. In press.
• Kim HJ, Perlman D, Tomic R. Natural History of Idiopathic Pulmonary Fibrosis. Respiratory Medicine 2015; doi:10.1016/j.med.2015.02.002
• Keenan J, Miller E, Jessurun J, Allen T, Kim HJ. IgG4-related disease of the lung: A Case Series of 6 patients and review of the literature. Sarcoidosis Vasculitis and Diffuse Lung Diseases. In press.